IASIS PHARMA is a Greek Pharmaceutical Company active in the Production, R&D, Export and Trade of Pharmaceutical Products, Medical Devices and Cosmetics, with special focus on niche market therapeutic categories. IASIS PHARMA manufacturing facilities have been into operation since 1985. They have been renovated and upgraded twice according to Greek and EU Legislations, operating under the strictest GMP, GLP and GDP regulations. In 2012 the manufacturing plant has expanded with the addition of a new automatic production and packaging line for effervescent tablets. In 2016 IASIS PHARMA went ahead to acquire a new property in Attica where it now has under construction new Production Facilities, a Logistics & Distribution Center as well as a Research & Development Center. IASIS PHARMA is one of the major suppliers of the Greek Pharmaceutical market with high quality products, having a strong export operation, supplying EU, other European Countries, Middle East and North Africa with branded and/or private label medicinal and OTC products.
| Website | https://iasispharma.com/ |
| Revenue | $6 million |
| Employees | 99 (60 on RocketReach) |
| Founded | 1985 |
| Phone | +30 21 0231 1031 |
| Technologies |
JavaScript
,
HTML
,
PHP
+8 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Pharmaceutical Products, Medical Devices, Cosmetics Manufacturing, Drug Development, Research And Development, Export Pharmaceuticals, Pharmaceutical Trade, Drug Production, Healthcare, Manufacturing, R&D, Medical, Health, Beauty Products, Export, Trade |
| Competitors | Medigene AG, Amgen, Sobi - Swedish Orphan Biovitrum AB (publ), Bristol Myers Squibb, AstraZeneca, Teva Pharmaceuticals, Novartis, Lilly India, Roche, Receptos, a wholly-owned subsidiary of Celgene +43 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular IASIS PHARMACEUTICALS HELLAS S.A. employee's phone or email?
The IASIS PHARMACEUTICALS HELLAS S.A. annual revenue was $6 million in 2026.
Konstantinos Pachis is the Founder, President and Managing Director of IASIS PHARMACEUTICALS HELLAS S.A..
60 people are employed at IASIS PHARMACEUTICALS HELLAS S.A..
The NAICS codes for IASIS PHARMACEUTICALS HELLAS S.A. are [32541, 325, 3254, 32].
The SIC codes for IASIS PHARMACEUTICALS HELLAS S.A. are [283, 28].